Palbociclib plus endocrine therapy versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (Young-PEARL): overall survival analysis of a randomised, open-label, phase 2 study

Hee Kyung Ahn & Soo Jung Hong et al. · 2025-02-17

Authors
Hee Kyung Ahn, Ji-Yeon Kim, Kyung-Hun Lee, Gun Min Kim, Seok Yun Kang, Keun Seok Lee, Jee Hyun Kim, Kyong Eun Lee, Moon Hee Lee, Hee-Jun Kim, Han Jo Kim, Su-Jin Koh, In Hae Park, Joohyuk Sohn, Sung-Bae Kim, Jin Seok Ahn, Seonwoo Kim, Hyun Cho, Kyung Hae Jung, Seock-Ah Im, Yeon Hee Park, Woong Yang Park, Jung Hoon Shin, Seok Jin Nam, Jeong Eon Lee, Seok Won Kim, Yoon La Choi, Jong Han Yu, Miso Kim, Tae-You Kim, Do-Youn Oh, Tae Yong Kim, Dae-Won Lee, Changhee Park, Min Hwan Kim, Hye Hyun Jung, Jae Ho Jung, Jin Hee Ahn, Young Mi Kwon, Sung Hoon Sim, Yu Jung Kim, Se Hyun Kim, Koung Jin Suh, Joo Han Lim, Jin Hyun Cho, Jong In Lee, Seung Take Lim, Shin Young Hyun, Soo Jung Hong